论文部分内容阅读
目的 :对脑血康胶囊和脑血康口服液进行药效学比较。方法 :用脑血管阻力、血瘀模型动物血栓形成、红细胞电泳、微循环、纤溶酶活性、纤维蛋白原含量、皮下瘀血吸收等方法进行比较实验。结果 :脑血康胶囊、脑血康口服液均可显著降低脑血管阻力、改善微循环、抑制血栓形成、加快红细胞电泳速度、加快皮下瘀血吸收 ,并有一定增加纤溶酶活性、降低纤维蛋白原含量等作用。结论 :脑血康胶囊和脑血康口服液有同样药理作用 ,脑血康胶囊作用强于脑血康口服液
Objective : To compare the pharmacodynamics of Naoxuekang capsule and Naoxuekang oral liquid. Methods :Comparative experiments were performed with cerebrovascular resistance, thrombosis of blood stasis models, red blood cell electrophoresis, microcirculation, plasmin activity, fibrinogen content, subcutaneous hemorrhagic blood absorption and other methods. Results: Naoxuekang capsule and Naoxuekang oral liquid can significantly reduce cerebral vascular resistance, improve microcirculation, inhibit thrombosis, speed up red blood cell electrophoresis speed, accelerate subcutaneous hemorrhagic absorption, and increase plasmin activity and decrease fiber content. Protein content and other effects. Conclusion: Naoxuekang capsule and Naoxuekang oral liquid have the same pharmacological effects. Naoxuekang capsule is stronger than Naoxuekang oral liquid.